Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesSurvival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine and dacarbazine chemotherapy
Journal of Clinical Endocrinology and Metabolism, 06/09/09
Nomura K et al. - In a study to analyze survival curves and survival times of pts with malignant pheochromocytoma and determine the efficacy of chemotherapy on prolongation of life, this study revealed a long survival time. Vincristine and dacarbazine (CVD) chemotherapy was not shown to extend survival, especially for women and pts with adrenal gland-derived primary tumors.
Methods- This was an inception cohort and Kaplan-Meier survival analysis.
- 32 pts with metastasized malignant pheochromocytoma were analyzed for survival.
- 25 pts had undergone excision of their primary tumors.
- Survival curves were compared among 16 pts in the group treated with combined chemotherapy using CVD and 9 pts not treated with chemotherapy.
- The survival curve of the 32 pts declined continuously and linearly to at least 20 yrs after diagnosis of pheochromocytoma.
- The 50% survival rate was estimated to be 14.7 yrs.
- In the 25 pts whose primary tumor was excised, pts who already had metastases at the time of pheochromocytoma diagnosis had better survival than those whose metastases were found later.
- Survival rate after diagnosis of metastasis was worse in the CVD group than in controls.
- When the effects of CVD were examined after stratifying several factors, female gender and adrenal origin of tumor were found to be negative prognostic factors for CVD chemotherapy.
Today in Adrenal Glands...keeping you current
Receive free subspecialty "5-minute updates" via email
Outcomes From 3144 Adrenalectomies in the United States
Archives of Surgery, 12/07/09
High frequency of SNAIL-expressing cells confirms and predicts metastatic potential of phaeochromocytoma
Endocrine-Related Cancer, 12/07/09
Diagnosis of Adrenal Insufficiency Using the GHRP-6 Test: Comparison with the Insulin Tolerance Test in Patients with Hypothalamic-Pituitary-Adrenal Disease
Hormone and Metabolic Research, 12/02/09
Today in Endocrine Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role
Endocrine-Related Cancer, 12/07/09
Aggressive inherited and sporadic medullary thyroid carcinomas display similar oncogenic pathways
Endocrine-Related Cancer, 12/07/09
Reproductive disturbances in multiple neuroendocrine tumor syndromes
Endocrine-Related Cancer, 12/07/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Evidence-Based Medicine, 12/07/09
In patients with type 2 diabetes, perindopril-indapamide had similar relative reductions in mortality and cardiac events regardless of AF status
Evidence-Based Medicine, 12/07/09
The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case-control study
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 12/04/09
Sponsor
Article Search
Sponsor